News
Following a meeting with the US FDA, clinical-stage biotech Dimerix has confirmed the appropriate primary endpoint for full ...
Morgan Rich, a living recipient, and her father, Lowell Ghosley, her kidney donor, highlight their advocacy for organ ...
More than 100,000 people nationwide, including 5,000 in the Philadelphia area, are waiting for organ donations, a reality ...
Doctors discovered that one of her kidneys was leaking too much protein during a routine check-up and decided to do ...
A mother and daughter are graduating from nursing school together after going through a medical journey of their own.
6don MSN
We went back in to get the results, and he pretty much said you won’t live if you don’t get a kidney or dialysis,” recalled ...
After being rushed to the emergency room with severe stomach pain, McConnell-Brent learned the problem was her kidneys and ...
After being rushed to the emergency room with severe stomach pain, McConnell-Brent learned the problem was her kidneys and ...
15d
MedPage Today on MSNNKF Roundup: Phosphate Binder Barriers, OTC Pills and Stones, Bad Itching, and MoreWhy Don't Patients Take Their Phosphate Binders? Online survey findings showed significant challenges with compliance to phosphate binder therapy. Among 200 dialysis patients, 37% were non-compliant ...
Going into 2025, US equities surged off the back of expectations that Donald Trump’s election victory would attract increased capital to the US economy. As Trump continues to announce tariffs ...
Focal segmental glomerulosclerosis (FSGS) causes scarring that damages the kidney and affects about seven out of every million people each year, according to the Cleveland Clinic. Though there are ...
Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $30 from $32 and keeps an Outperform rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results